Clinical Trial Update: PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY [NA]

View source ↗

Summary

A clinical trial named PATHWAY-RCT aiming to prevent hospital admissions in patients with cardiac amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Snippet

Sponsor: Richmond Research Institute | Conditions: Cardiac Amyloidosis | NA | Status: RECRUITING